FMC Corporation has announced a comprehensive corporate reorganization under a plan called Project Foundation, approved by its Board of Directors. The initiative aims to optimize FMC's cost structure and organizational operations, with a major focus on redesigning its manufacturing footprint. The company plans to exit certain high-cost active ingredient and formulation plants, shifting production to lower-cost sources to enhance competitiveness against generics. Additional cost-reduction initiatives will be implemented in Asia, reflecting the planned sale of FMC's India commercial operations. The restructuring is expected to be substantially completed by the end of 2027. FMC also disclosed that, due to a significant decline in its stock price, it anticipates recording a non-cash impairment charge related to goodwill and intangible assets, which will not affect its operational cash flows.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000037785-25-000134), on December 12, 2025, and is solely responsible for the information contained therein.
Comments